Major federal actions over the past week marked a policy turning point for pharmacy benefit managers (PBMs), one that closely aligns with the evidence-based research led by USC researchers.
Requiring more financial transparency from PBMs would help policymakers understand how money flows through the large healthcare companies that now own them
A multidisciplinary team has developed a selective compound that inhibits an enzyme tied to inflammation in people at genetic risk for Alzheimer’s — while preserving normal brain function and crossing the blood-brain barrier.
Set to begin in the 2026-27 academic year, the new residency program is designed to prepare pharmacists for the unique challenges of serving the aging population across a variety of healthcare settings.
Darius Lakdawalla, professor of pharmaceutical economics and public policy, testified on Wednesday, Dec. 10, 2025, before the House Committee on Oversight and Government Reform.
Richard Dang, associate professor of clinical pharmacy, is the recipient of the American Pharmacists Association 2026 Good Government Pharmacist-of-the-Year Award.
The USC Mann School hosted its inaugural fall symposium, “The Future of Pharmacy Business and Practice” on Friday, November 14, which brought together a diverse group of healthcare leaders from across the country.
USC Mann has hired sports pharmacy specialist, Alexis Nicole Brown, PharmD ’25, who will work as a member of the interprofessional USC Athletics health care team.
